China Universal Asset Management Co., Ltd.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1906594 SHANGHAI, F4

Position in FULC

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$38,814

-$51,837 QoQ

Shares Held

10,605

-10.3% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#114

of 154 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

China Universal Asset Management Co., Ltd. holds $180,189,557 across 240 Biotechnology names. FULC ranks #208 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	48,265	$23,974,673
2	REGN	Regeneron Pharmaceuticals, Inc.	19,498	$12,157,782
3	ALNY	Alnylam Pharmaceuticals, Inc.	25,269	$7,606,727
4	RPRX	Royalty Pharma plc	120,547	$6,759,070
5	RVMD	Revolution Medicines, Inc.	33,835	$6,336,618
6	IONS	Ionis Pharmaceuticals Inc	76,302	$6,049,985
7	MRNA	Moderna, Inc.	63,149	$4,422,324
8	ARGX	Argenx SE	4,642	$4,306,708

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$38,814	10,605	-10.3%	Shares	Sole	2026-07-24
2026-03-31	$90,651	11,819	+34.0%	Shares	Sole	2026-04-28
2025-12-31	$99,742	8,819	-26.5%	Shares	Sole	2026-01-29
2024-09-30	$42,847	12,002	+64.4%	Shares	Sole	2024-10-25
2024-06-30	$45,266	7,301	-38.7%	Shares	Sole	2024-07-19
2024-03-31	$112,487	11,916	+66.7%	Shares	Sole	2024-05-21
2023-12-31	$48,262	7,150	+348.6%	Shares	Sole	2024-05-22
2023-09-30	$7,077	1,594	+96.8%	Shares	Sole	2024-05-22
2023-06-30	$2,673	810	-3.1%	Shares	Sole	2024-05-22
2023-03-31	$2,382	836	+58.0%	Shares	Sole	2024-05-22
2022-12-31	$3,851	529	+8.6%	Shares	Sole	2024-05-22
2022-09-30	$3,939	487	—	Shares	Sole	2022-10-21
No filing history on record for this holder in this stock.